Anyone who is interested in vein treatment medicine as more than just a medical procedure but also as an investment will know that stock shares of VNUS Medical Technologies have been on the rise since last year. With a recent announcement that they turned profits in the second quarter, VNUS has managed to cause another surge in its stocks.
"Vnus said Tuesday afternoon that it earned $9.2 million, or 56 cents per share, for the three months ended June 30, marking its first profitable quarter since the fourth quarter of 2005. A year ago, Vnus posted a loss of $2.3 million, or 15 cents per share. Revenue increased 86 percent to $31.9 million from $17.2 million."
There are some people who are continuing to recommend that people invest in VNUS today. Others say that the company is about to hit its peak and that if you didn't get in early then you might not want to bother now.
Question of the Day: Are VNUS stocks going to continue to rise?
